Active Clinical Trials

Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.

Showing 169 results
  • Sort by
  • Study title
  • Condition
  • Phase
  • Location
Study title Condition Phase Location

Study of Out of Specification for Tisagenlecleucel

 		B-cell Acute Lymphoblastic Leukemia, Diffuse Large B-cell Lymphoma Phase3 Japan NCT04094311

Kesimpta Pregnancy and Infant Safety Study Using Real World Data

 		Multiple Sclerosis Switzerland NCT06156683

Post-Authorization Safety Study for Assessment of Pregnancy Outcomes in Patients Treated With Mayzent

 		Multiple Sclerosis United States NCT04933552

A Prospective Observational Study to Describe Clinical Outcomes, Treatment Patterns, Patients Characteristics Among Patients With HR+/HER2- Advanced BC Initiating Treatment With Risarg®, Piqray®, Endocrine Therapy or Chemotherapy in Routine Clinical Practice in Russia

 		Breast Cancer Russian Federation NCT04943497

Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN

 		C3 Glomerulopathy, Immune-complex-membranoproliferative Glomerulonephritis Phase3 Argentina
Brazil
China
Czechia
France
Germany
Greece
Israel
Italy
Japan
Netherlands
Spain
Switzerland
Turkey
United Kingdom
United States
View All
 NCT03955445

Patient's Perspective on the Evolution of Hidradenitis Suppurativa Burden After Secukinumab Initiation

 		Hidradenitis Suppurativa France NCT06444087

Regulatory Post-Marketing Surveillance Study for Brolucizumab

 		Neovascular Age-related Macular Degeneration Korea, Republic of NCT04985487

Efficacy, Safety and Tolerability of KLU156 in Adults and Children ≥ 5 kg Body Weight With Uncomplicated P. Falciparum Malaria

 		Uncomplicated Plasmodium Falciparum Malaria Phase3 Burkina Faso
Congo, The Democratic Republic of the
Côte D'Ivoire
Gabon
Ghana
India
Kenya
Mali
Niger
Rwanda
Tanzania
Uganda
Zambia
View All
 NCT05842954

A PMS of Jakavi® in Patients With Steroid-Refractory Graft-versus-Host Disease (SR-GvHD) in Korea

 		Graft-versus-Host Disease Korea, Republic of NCT05621733

Study of Lutetium (177Lu) Vipivotide Tetraxetan in mCRPC Participants With Moderately and Severely Impaired and With Normal Renal Function

 		Metastatic Castration-Resistant Prostate Cancer (mCRPC) Phase2 France
Germany
Italy
Spain
United States
View All
 NCT06004661